Amerise Biosciences Limited (BOM:531681)
0.7500
-0.0100 (-1.32%)
At close: Jul 23, 2025
Amerise Biosciences Revenue
In the fiscal year ending March 31, 2025, Amerise Biosciences had annual revenue of 1.88M INR with 423.68% growth. Amerise Biosciences had revenue of 1.88M in the quarter ending March 31, 2025, with 425.14% growth.
Revenue
1.88M
Revenue Growth
+423.68%
P/S Ratio
26.71
Revenue / Employee
n/a
Employees
n/a
Market Cap
50.21M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 1.88M | 1.52M | 423.68% |
Mar 31, 2024 | 359.00K | 271.00K | 307.95% |
Mar 31, 2023 | 88.00K | -95.69M | -99.91% |
Mar 31, 2022 | 95.77M | 97.46M | -5,768.30% |
Mar 31, 2021 | -1.69M | -1.70M | -29,618.54% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,765.41B |
HDFC Bank | 2,736.06B |
Bharti Airtel | 1,729.85B |
Tata Consultancy Services | 2,561.48B |
ICICI Bank | 2,054.85B |
State Bank of India | 3,429.39B |
Infosys | 1,647.16B |
Bajaj Finance | 370.20B |